{
    "organizations": [],
    "uuid": "0fe529c14d180f5d997fce02aecffc3ceffc7be3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-transgene-says-first-patient-dosed/brief-transgene-says-first-patient-dosed-in-china-in-trial-of-t101-idUSFWN1PC0UG",
    "ord_in_thread": 0,
    "title": "BRIEF-Transgene Says ‍First Patient Dosed In China In Trial Of T101​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17 (Reuters) - TRANSGENE SA:\n* ‍FIRST CHRONIC HEPATITIS B PATIENT DOSED IN CHINA IN A PHASE 1 TRIAL OF T101​\n* ‍FIRST DATA READOUT FROM STUDY IS EXPECTED AT BEGINNING OF 2019​\n* ‍TRIAL WILL INCLUDE UP TO 36 PATIENTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)\n ",
    "published": "2018-01-18T00:55:00.000+02:00",
    "crawled": "2018-01-18T16:25:25.050+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "transgene",
        "sa",
        "chronic",
        "hepatitis",
        "b",
        "patient",
        "dosed",
        "china",
        "phase",
        "trial",
        "data",
        "readout",
        "study",
        "expected",
        "beginning",
        "include",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}